A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes

Clinical trial NCT06471530 · COMPLETED

Trial details

NCT number: NCT06471530
Sponsor: Immunwork, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2024-07-09
Primary completion: 2025-01-03
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.